Skip to main content Skip to section navigation Skip to footer
Global leader in temperature-controlled supply chain solutions for the life sciences
Cryport, Inc. Corporate Home
  • About Us
    • Company History
    • Management Team
  • Cryoport’s Business Units
  • ESG Policy
  • Investor Relations
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact Us
    • Careers

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Company Profile
    • Executive Team
    • Contacts
    • Information Request
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
Apr 27, 2023 8:30 am EDT
Cryoport to Report First Quarter 2023 Financial Results on May 4, 2023
Apr 25, 2023 8:30 am EDT
Cryoport Signs New Supply Chain Solutions Agreement with Boston IVF to Support Reproductive Material Shipments Across the U.S.
Mar 28, 2023 8:30 am EDT
Cryoport Announces Multi-Year Agreement with Inception Fertility
Mar 13, 2023 6:00 am EDT
Cryoport Confirms No Financial Exposure to Silicon Valley Bank
Mar 08, 2023 1:15 pm EST
Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company – A Uniquely Positioned Ticker In The Weeds?
Mar 08, 2023 1:15 pm EST
Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company – A Uniquely Positioned Ticker In The Weeds?
Feb 23, 2023 4:05 pm EST
Cryoport Reports Fourth Quarter and Full Year 2022 Results
Feb 15, 2023 8:30 am EST
Cryoport to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
Jan 18, 2023 8:30 am EST
Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
Dec 20, 2022 8:30 am EST
Cryoport to Present at the J.P. Morgan 41st Annual Healthcare Conference
  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 39
  • Next Pagearrow_forward
rss_feed News RSS
  • Accessibility statement
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
  • Sitemap
  • Cryoport Systems
  • MVE Biological Solutions
  • CRYOPDP
  • CRYOGENE
  • About Us
  • Cryoport’s Family of Companies
  • ESG Policy
  • Investor Relations
  • Contact Us
  • About Us
  • Cryoport’s Family of Companies
  • ESG Policy
  • Investor Relations
  • Contact Us
Cryoport, Inc. logo
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Careers
  • Newsletter
  • Manage Cookie Preferences

Cryoport Inc.
112 Westwood Place, Suite 350
Brentwood, TN 37027

Receive Financial Updates
  • youtube
  • x
  • linkedin

Investor Contacts

Scott Eckstein
seckstein@kcsa.com

Todd Fromer
tfromer@kcsa.com

Cryoport, Inc. logo

Cryoport Inc.
112 Westwood Place, Suite 350
Brentwood, TN 37027

©2025 Cryoport Inc. All Rights Reserved.

  • youtube
  • x
  • linkedin